IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Onconova Therapeutics Inc

CUSIP: 68232V405 | 97 institutional holders

Quarters

Q4 2023Q1 2022Q4 2021Q2 2021Q1 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2023

Cornerstone Planning Group LLC33
0.0% of portfolio›$25
StyleTurnoverLocationFiled
Cornerstone Planning Group LLC
33$250.0%ETFMediumFairfield, NJ2024-02-12